| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0003 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.24 | 0.0003 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.2 | 0.0005 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.18 | 0.0006 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |